Hims & Hers Insider: Michael Chi Gifts 5,700 Shares and Executes 10b5-1 Plan
Rhea-AI Filing Summary
Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc. (HIMS), reported multiple transactions on Form 4. On 03/07/2025 he disposed of 5,700 Class A shares as a gift to a donor-advised fund, leaving 291,439 shares beneficially owned. On 09/24/2025 he exercised 2,100 stock options with an exercise price of $5.01 under a Rule 10b5-1 trading plan adopted 03/04/2025, and concurrently sold 2,100 shares at $56.52. The Form 4 shows 2,100 underlying shares from the options and indicates total Class A beneficial ownership figures of 174,042 shares for options and 291,439–293,539 shares across reported lines. The filing discloses that the options vest over a four-year service schedule that began in 03/2022.
Positive
- Transactions fully disclosed on Form 4 with transaction codes, quantities, prices, and explanations
- Use of a Rule 10b5-1 trading plan adopted 03/04/2025 provides pre-arranged, documented execution of option exercise and sale
- Charitable gift of 5,700 shares to a donor-advised fund is explicitly reported
Negative
- Insider sale of 2,100 shares on 09/24/2025 at $56.52 could be viewed negatively by some investors due to insider liquidation
- Reduction in direct ownership following the gift and sale transactions is reported, lowering immediate beneficial holdings
Insights
TL;DR Insider executed a Rule 10b5-1 plan to exercise options and sell shares while also gifting shares to a donor-advised fund.
The reporting shows routine insider activity rather than an unexplained one-off. The 03/07/2025 entry documents a charitable gift of 5,700 Class A shares reducing direct holdings to 291,439 shares. The 09/24/2025 transactions were effected under a documented Rule 10b5-1 plan adopted 03/04/2025, with exercise at $5.01 and sale at $56.52 of 2,100 shares, reflecting option monetization under an established trading plan. The filing also clarifies the service-based vesting schedule for the options that began in March 2022 and vests monthly over four years.
TL;DR Disclosure is complete and follows standard protocols: gift, documented 10b5-1 plan, and vesting terms disclosed.
The Form 4 includes required details: transaction codes, quantities, prices, the existence and adoption date of a 10b5-1 plan, and an explanation that 5,700 shares were gifted to a donor-advised fund. Vesting terms for the options are specified as service-based with inception in March 2022. Signatures and filing dates are present, indicating procedural compliance with Section 16 reporting obligations. No additional material disclosures such as unusual option repricing or related-party transactions are reported in the document.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 2,100 | $0.00 | -- |
| Exercise | Class A Common Stock | 2,100 | $5.01 | $11K |
| Sale | Class A Common Stock | 2,100 | $56.52 | $119K |
| Gift | Class A Common Stock | 5,700 | $0.00 | -- |
Footnotes (1)
- These shares represent a gift to a Donor Advised Fund. The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 4, 2025 by the Reporting Person. The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting on March 24, 2022, and 1/48th of the options vesting monthly thereafter.
